Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - June 2014


SMi ADMET 2014

30 Jun 2014 - 01 Jul 2014 - London, UK



Bookmark and Share


SMi presents the 9th annual conference on: ADMET

Enhancing drug quality by ADMET optimisation in discovery

SMi’s established ADMET conference has been a premier event in its field for almost a decade. The 9th annual event taking place on 30th June and 1st July in central London, will bring together even more industry leading experts to deliver over eighteen case study driven presentations. A focal point for anyone working in the market for drug discovery and development, attending provides a unique forum to engage with KOL’s and experts active in the field.

ADMET 2014 will enable delegates to gain valuable insights into enhancing drug quality by ADMET optimisation in discovery. It will focus on themes including Predictive ADME, Screening Approaches, Predictive Toxicology, Drug to Drug interactions and emerging issues such as regulatory changes. Click here for the agenda  

 Previous events in the ADMET series have received positive feedback from the industry including, 

"Excellent" – Pharmidex, "Nice mix of attendees" – Grunenthal, "Good conference at general level to update your current knowledge" - Orion Corporation and "Great conference…well organised" - Sanofi

Key Speakers Include:

  • Natalie Gobeau, Metabolism and Pharmacokinetics, Novartis
  • Dietmar-Weitz, Lab Head/ADME In Vitro Systems, Sanofi-Aventis
  • Sarah Baldwin, In Vitro DMPK Manager, GSK
  • Chris Powell, VP Safety Assessment, GSK
  • Georg Schmitt, Head of Toxicology, Roche Pharmaceuticals
  • Richard Thompson, Principal Scientist, AstraZeneca
  • Franck Atienzar, Associate Director, In Vitro and In Silico Toxicology, UCB
  • Adina Tocoian, Senior Clinical Pharmacologist, UCB
  • David Fairman, Senior Clinical Pharmacokinetist, MedImmune

Reasons to Attend:

  • Understand how to integrate ADME and toxicity data to enhance the prediction and understanding of drug safety in humans 
  • Hear the latest updates on drug transporters including the evolving transporter strategies in drug development and the different roles of drug transporters in R&D 
  • Explore the ADME properties of peptides in drug discovery 
  • Evaluate and overcome the challenges of making an accurate human dose prediction 

Registration is now live. Click here to secure your place today and save £300.

For further details and to book your place, visit: http://www.smi-online.co.uk/goto/2014admet8.asp

Alternatively contact the Team on +44 (0)20 7827 6000 or email events@smi-online.co.uk 



Further information
Scientific News
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Growing Stem Cells More Safely
Nurturing stem cells atop a bed of mouse cells works well, but is a non-starter for transplants to patients – Brown University scientists are developing a synthetic bed instead.
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Potential Target for Revolutionary Antibiotics
An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!